Case Report: Camrelizumab combined with gemcitabine and oxaliplatin in the treatment of advanced intrahepatic cholangiocarcinoma: a case report and literature review

Intrahepatic cholangiocarcinoma (ICC) is one of the most common invasive malignant tumors, with a 5-year survival rate of less than 5%. Currently, radical surgical resection is the preferred treatment for ICC. However, most patients are only diagnosed at an advanced stage and are therefore not eligi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhongyan, Wang, Xin, Li, Hehe, Sun, Huimin, Chen, Jianhong, Lin, Hongfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475830/
https://www.ncbi.nlm.nih.gov/pubmed/37671157
http://dx.doi.org/10.3389/fimmu.2023.1230261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475830/
https://www.ncbi.nlm.nih.gov/pubmed/37671157
http://dx.doi.org/10.3389/fimmu.2023.1230261

Ejemplares similares